CCR5 and type 2 diabetes mellitus: Power assuming α = 0.05 and relative risk of 1.4 was 62%, 83%, 85% and 79% for type 2 diabetic patients with diabetic nephropathy for IL8, CCL2, CCR5, MMP9 polymorphisms (p<0.05) among North Indian population.